Alterity Therapeutics

1 follower

Alterity is developing first-in-class therapies to treat neurodegenerative disease.

Industries

Employees

11-50

Links


Org chart

David Stamler
Chief Executive Officer
Collapse
Margaret Bradbury
VP, Nonclinical Development
Jim Kerr
Vice President, CMC
Tara Speranza
Head of Investor Relations and Communications
Cynthia Wong
Vice President Clinical Operations

Board & advisors

Lawrence Gozlan
Non-Executive Director
Peter Marks
Non-Executive Director
Brian Meltzer
Non-Executive Director
Geoffrey Paul Kempler
Non-Executive Chairman